Latest Breaking News On - Berlin centre for - Page 1 : comparemela.com

Dengue vaccine, QDENGA, Approved for Use in European Union

Dengue vaccine, QDENGA, Approved for Use in European Union
outbreaknewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outbreaknewstoday.com Daily Mail and Mail on Sunday newspapers.

Gary dubinTomas jelinekEuropean unionEuropean commissionBerlin centre forDengue tetravalent vaccineEuropean medicines agencyMedicinal productsHuman useGlobal vaccine business unitMedical directorBerlin centreTropical medicineScientific directorDengue efficacy study

Takeda s QDENGA▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

08.12.2022 - Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) granted marketing authorization for the company’s dengue vaccine QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) for the prevention of dengue disease in .

Sri lankaUnited statesDominican republicTakeda yakuhin kogyoTomas jelinekWorld health organizationBerlin centre forData monitoring committeeExchange commissionEuropean union eu member statesTakeda pharmaceutical company limitedEuropean centre for disease preventionMedical directorBerlin centreTropical medicineScientific director

Takeda s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

L’AFP est une agence d’information globale, assurant une couverture rapide, complète et vérifiée des événements de l’actualité comme des thèmes qui façonnent notre quotidien. Avec un réseau de journalistes sans égal, déployé sur 151 pays, l'AFP est en outre un leader mondial de l’investigation nu.

Sri lankaUnited statesDominican republicGary dubinRachel higginsTomas jelinekJun saitoEuropean commissionInternational mediaBerlin centre forData monitoring committeeExchange commissionBusiness wire incEuropean union eu member statesEuropean unionTakeda pharmaceutical company limited

Takeda Pharmaceutical Company Limited: Takeda s QDENGA? (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

The European Commission Approved QDENGA (TAK-003) for Use in Individuals Four Years of Age and Olderi QDENGA Becomes the Only Dengue Vaccine Approved in the EU for Use in Individuals Regardless of Previous

Sri lankaUnited statesDominican republicGary dubinRachel higginsTomas jelinekJun saitoEuropean commissionWorld health organizationInternational mediaBerlin centre forData monitoring committeeExchange commissionEuropean commission approvedEuropean union eu member statesEuropean union

Takeda s QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union | Vaccines

Takeda’s QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

United statesSri lankaDominican republicGary dubinTomas jelinekEuropean commission approvedEuropean union eu member statesEuropean unionEuropean commissionBerlin centre forData monitoring committeeDengue tetravalent vaccineIndividuals four yearsOnly dengue vaccine approvedIndividuals regardlessPrevious dengue